The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vereshchagina A.V.

National Medical Research Center of Cardiology

Uskach T.M.

Sapelnikov O.V.

Amanatova V.A.

National Medical Research Center of Cardiology

Grishin I.R.

Gusejnli E.G.

Kostin V.S.

National Medical Research Center of Cardiology

Akchurin R.S.

Chazov National Medical Research Centre of Cardiology

Preimplantation screening of patients-candidates for implantation of a subcutaneous cardioverter-defibrillator: predictors of the outcomes

Authors:

Vereshchagina A.V., Uskach T.M., Sapelnikov O.V., Amanatova V.A., Grishin I.R., Gusejnli E.G., Kostin V.S., Akchurin R.S.

More about the authors

Journal: Russian Cardiology Bulletin. 2021;16(4): 58‑65

Read: 1835 times


To cite this article:

Vereshchagina AV, Uskach TM, Sapelnikov OV, et al. . Preimplantation screening of patients-candidates for implantation of a subcutaneous cardioverter-defibrillator: predictors of the outcomes. Russian Cardiology Bulletin. 2021;16(4):58‑65. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20211604158

Recommended articles:

References:

  1. Engdahl J, Holmberg M, Karlson B, Luepker R, Herlitz J. The epidemiology of out-of-hospital «sudden» cardiac arrest. Resuscitation. 2002;52(3):235-245.  https://doi.org/10.1016/s0300-9572(01)00464-6
  2. Boersma LV, El-Chami MF, Bongiorni MG, Burke MC, Knops RE, Aasbo JD. Gold MR Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. Heart Rhythm. 2019;16(11):1636-1644. https://doi.org/10.1016/j.hrthm.2019.04.048
  3. Moss AJ, Hall WJ, Cannom, DS, Daubert JP, Higgins SL, Klein H, Heo M. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia. New England Journal of Medicine. 1996;335(26):1933-1940. https://doi.org/10.1056/nejm199612263352601
  4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Andrews ML. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. New England Journal of Medicine. 2002;346(12):877-883.  https://doi.org/10.1056/nejmoa013474
  5. Kong MH, Fonarow G C, Peterson ED, Curtis AB, Hernandez AF, Sanders GD, Thomas KL, Hayes DL, Al-Khatib SM. Systematic review of the incidence of sudden cardiac death in the United States. Journal of the American College of Cardiology. 2011;57(7):794-801.  https://doi.org/10.1016/j.jacc.2010.09.064
  6. Kamp NJ, Al-Khatib SM. The subcutaneous implantable cardioverter-defibrillator in review. American Heart Journal. 2019;217:131-139.  https://doi.org/10.1016/j.ahj.2019.08.010
  7. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R; REPLACE Registry Investigators. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553-1561. https://doi.org/10.1161/circulationaha.110.976076
  8. Habib A, Le KY, Baddour LM, Friedman PA, Hayes DL, Lohse CM, Sohail MR. Predictors of Mortality in Patients With Cardiovascular Implantable Electronic Device Infections. The American Journal of Cardiology. 2013;111(6):874-879.  https://doi.org/10.1016/j.amjcard.2012.11.052
  9. Kaya E, Rassaf T, Wakili R. Subcutaneous ICD: Current standards and future perspective. International Journal of Cardiology. Heart and Vasculature. 2019;24:100-409.  https://doi.org/10.1016/j.ijcha.2019.100409
  10. Honarbakhsh S, Providencia R, Srinivasan N, Ahsan S, Lowe M, Rowland Lambiase P. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. International Journal of Cardiology. 2017;228:280-285.  https://doi.org/10.1016/j.ijcard.2016.11.017
  11. Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. American Heart Journal. 2012;163(5):753-760.  https://doi.org/10.1016/j.ahj.2012.02.012
  12. Priori SG, Blomström-Lundqvist C. European Society of Cardiology Guidelines 2015 for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. European Heart Journal. 2015;36(41):2757-2759. https://doi.org/10.1093/eurheartj/ehv445
  13. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138(13):272-391.  https://doi.org/10.1161/cir.0000000000000549
  14. Segreti L, Rinaldi CA, Claridge S, Svendsen JH, Blomstrom-Lundqvist C, Auricchio A. Butter C, Dagres N, Deharo JC, Maggioni AP, Kutarski A, Kennergren C, Laroche C, Kempa M, Magnani A, Casteigt B, Bongiorni MG. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis. Europace. 2019;21(4):645-654.  https://doi.org/10.1093/europace/euy307
  15. Lebedev DS, Mikhailov EN, Neminuschiy NM, Golukhova EZ, Babokin VE, Bereznitskaya VV, Vasichkina ES, Garkina SV, Golitsyn SP, Davtyan KV, Duplyakov DV, Zaklyazminskaya EV, Zenin SA, Ivanitsky EA, Ildarova RA, Komolyatova VN, Kostareva AA, Kuchinskaya EA, Lajovich (Nesterenko) LYu, Lebedeva VK, Lyubimtseva TA, Makarov LM, Mamchur SE, Medvedev MM, Mironov NYu, Mitrofanova LB, Popov SV, Revishvili ASh, Rzayev FG, Romanov AB, Tatarsky RB, Termosesov SA, Utsumueva MD, Kharlap MS, Tsaregorodtsev DA, Shkolnikova MA, Shlevkov NB, Shlyakhto EV, Shubik YuV, Yashin SM. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Rossijskij kardiologicheskij zhurnal. 2021;26(7):128-189. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4600
  16. Chang SC, Patton KK, Robinson MR, Poole JE, Prutkin JM. Subcutaneous ICD screening with the Boston Scientific ZOOM programmer versus a 12-lead ECG machine. Pacing and Clinical Electrophysiology. 2018;41(5):511-516.  https://doi.org/10.1111/pace.13314
  17. Olde Nordkamp LRA, Warnaas JLF, Kooiman KM, de Groot JR, Rosenmoller B RAM, Wilde AAM, Knops RE. Which Patients Are Not Suitable for a Subcutaneous ICD: Incidence and Predictors of Failed QRS-T-Wave Morphology Screening. Journal of Cardiovascular Electrophysiology. 2014;25(5):494-499.  https://doi.org/10.1111/jce.12343
  18. Zeb M, Curzen N, Veldtman G, Yue A, Roberts P, Wilson D, Morgan J. Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping. Europace. 2015;17(7):1059-1067. https://doi.org/10.1093/europace/euu375
  19. Maurizi N, Olivotto I, Olde Nordkamp LRA, Baldini K, Fumagalli C, Brouwer TF, Cecchi F. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2016;13(2):457-463.  https://doi.org/10.1016/j.hrthm.2015.09.007
  20. Guo L, Zhang M, Hu M, Wang B, Wang J, Zuo L, Liu L. Prevalence of subcutaneous implantable cardioverter-defibrillator based on template ECG screening and ineligible surface ECG predicting factors in patients with hypertrophic cardiomyopathy in China. Heart and Vessels. 2018;34(5):851-859.  https://doi.org/10.1007/s00380-018-1300-8

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.